VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) traded up 52.9% during trading on Thursday . The stock traded as high as C$0.15 and last traded at C$0.13. 1,350,857 shares traded hands during mid-day trading, an increase of 732% from the average session volume of 162,400 shares. The stock had previously closed at C$0.09.
VentriPoint Diagnostics Trading Up 70.6 %
The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56. The stock has a market capitalization of C$23.52 million, a price-to-earnings ratio of -4.48 and a beta of 0.39. The company’s 50-day moving average is C$0.10 and its 200-day moving average is C$0.13.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Further Reading
- Five stocks we like better than VentriPoint Diagnostics
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- The Role Economic Reports Play in a Successful Investment Strategy
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- What Are Dividend Champions? How to Invest in the Champions
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
